Journal profile · Biochemistry & Molecular Biology
Journal of Receptors and Signal Transduction
ISSN 1079-9893 · eISSN 1532-4281 · Informa Healthcare · UNITED STATES · Quarterly · Founded 1995
Journal of Receptors and Signal Transduction: CAS Zone 4 · Biology (2025 upgraded edition); impact factor 1.98; subscription journal; median 126 days to acceptance (48 articles, last 24 months); community-reported acceptance: fairly easy; 26 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Receptors and Signal Transduction is published by Informa Healthcare and is in Zone 4 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Receptor Mechanisms and Signaling, Neuropeptides and Animal Physiology and Computational Drug Discovery Methods, together about 39.1% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Journal of Receptors and Signal Tranduction is included in the following abstracting and indexing services: BIOBASE; Biochemistry and Biophysics Citation Index; Biological Abstracts; BIOSIS Full Coverage Shared; BIOSIS Previews; Biotechnology Abstracts; Current Contents/Life Sciences; Derwent Chimera; Derwent Drug File; EMBASE; EMBIOLOGY; Journal Citation Reports/ Science Edition; PubMed/MedLine; Science Citation Index; SciSearch; SCOPUS; SIIC.
Source: LetPub
Research area (LetPub): Biochemistry & Molecular Biology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology22.1%
- Neuropeptides and Animal PhysiologyNeuroscience9.2%
- Computational Drug Discovery MethodsComputer Science7.8%
- Neuroscience and Neuropharmacology ResearchNeuroscience6.2%
- Ion channel regulation and functionBiochemistry, Genetics and Molecular Biology5.1%
- Protein Kinase Regulation and GTPase SignalingBiochemistry, Genetics and Molecular Biology4.9%
- Monoclonal and Polyclonal Antibodies ResearchMedicine4.4%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology3.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Cell Biology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Cell Biology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Cell Biology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.98LetPub ·
- CiteScore 2026-06
- 5.9LetPub ·
- SJR 2026-06
- 0.6LetPub ·
- SNIP 2026-06
- 0.6LetPub ·
- h-index
- 42LetPub ·
- h-index
- 62OpenAlex ·
- i10-index
- 784OpenAlex ·
- 2-year mean citedness
- 1.87OpenAlex ·
- Self-citation rate
- 5.3%LetPub ·
- Share of gold OA articles
- 1.52%LetPub ·
Volume
- Articles per year
- 26LetPub ·
Articles by year OpenAlex count · 1,420 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 17 | 1 | 4 |
| 2025 | 26 | 3 | 49 |
| 2024 | 24 | 5 | 72 |
| 2023 | 17 | 1 | 115 |
| 2022 | 19 | 4 | 185 |
| 2021 | 43 | 12 | 523 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
126 daysMedian, submission to acceptance · P25–P75 92 days – 163 days
- Acceptance to online
- median 11 days (48 articles)
- Submission to online
- median 145 days
- Sample
- 48 articles with submission and acceptance dates (49 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Informa Healthcare
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 1995
- ISSN
- 1079-9893
- Electronic ISSN
- 1532-4281
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Journal of Receptors and Signal Transduction
What CAS zone is Journal of Receptors and Signal Transduction in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Receptors and Signal Transduction is in Zone 4 of Biology, and in Zone 4 of the minor category Biochemistry & Molecular Biology / Cell Biology. In the 2026 Xinrui edition it is in Zone 3 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Receptors and Signal Transduction?
The latest impact factor listed by LetPub is 1.98; CiteScore 5.9, h-index 62.
How long does peer review take at Journal of Receptors and Signal Transduction?
Based on the dates recorded on 48 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 126 days (interquartile range 92–163 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Journal of Receptors and Signal Transduction?
According to LetPub and DOAJ records, Journal of Receptors and Signal Transduction is indexed in SCIE and Scopus.
Is Journal of Receptors and Signal Transduction open access, and what is the APC?
Journal of Receptors and Signal Transduction is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .